XLRN
Acceleron Pharma
XLRN
XLRN
Delisted
XLRN was delisted on the 19th of November, 2021.
125 hedge funds and large institutions have $1.21B invested in Acceleron Pharma in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
49% less call options, than puts
Call options by funds: $9.66M | Put options by funds: $19.1M
Holders
125
Holding in Top 10
3
Calls
$9.66M
Puts
$19.1M
Top Buyers
| 1 | +$27M | |
| 2 | +$24.8M | |
| 3 | +$10.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.86M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$8.09M |
Top Sellers
| 1 | -$25.9M | |
| 2 | -$10.8M | |
| 3 | -$9.53M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.47M |
| 5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$2.99M |